Confidential Treatment Requested. (The Manager has omitted from this public Form 13F one or more holding(s) for which it is requesting confidential treatment from the U.S. Securities and Exchange Commission pursuant to section 13(f) of the Exchange Act and rule 24b-2 thereunder)
| Name | Title | City, State | Date |
|---|---|---|---|
| Santiago Donoso | CEO Provida | Santiago, Chile | 2/5/2024 |
On November 14, 2023, the Reporting Person filed its Form 13F Confidential Treatment Request for the quarter ended September 30, 2023 separately and confidentially with the U.S. Securities and Exchange Commission. However, the Reporting Person did not file a public Form 13F Holding Report at that time, and instead only filed an initial public Form 13F Confidential Treatment Request for the quarter ended September 30, 2023. As such, the Reporting Person is filing this Holding Report to report what it should have publicly filed on November 14, 2023, with the positions for which it requested confidential treatment omitted. Please note that this 13F Holdings Report filer is affiliated with MetLife Investment Management, LLC and Metropolitan Life Insurance Company who also file 13F Holdings Reports. Each entity files its own 13F Holdings Report because each entity has investment discretion over certain 13(f) securities reported. All three 13F Holdings Report filers are under common control of their ultimate parent, MetLife, Inc., who files a 13F Combination Report.
| Num | Name | Location | File Number |
|---|---|---|---|
| 1 | METLIFE INC | New York, NY | 028-18621 |